In 2001, plant biologist Kenneth Piller left a research position with agricultural biotech company Monsanto to follow his wife to Charlotte, North Carolina. There, he took a job teaching plant biology as an adjunct professor at the University of North Carolina. Down the hall from Piller's office was immunologist Kenneth Bost, who was trying to produce a viral protein in wheat to use as a vaccine. Piller recognized in Bost's project a way to get back into research, and Bost saw in Piller’s expertise a way to fill in the gaps in his own knowledge. "I knew I didn’t have the expertise to move forward," Bost says. The pair soon realized they were onto something big: In 2005, Bost and Piller founded a biotechnology research company calledSoyMeds focused on developing soy-based vaccines and other therapies. If they succeed, medicines may one day be delivered via a swig of soy milk.